Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses - Concepedia

Concepedia

Publication | Open Access

Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses

DOI Full Paper Access

653

Citations

10

References

2011

Year

Greg Yothers, Michael J. O’Connell, Carmen J. Allegra, J. Philip Kuebler, Linda H. Colangelo, Nicholas J. Petrelli, Norman Wolmark

Journal of Clinical Oncology

Abstract

Overall, the addition of oxaliplatin to FULV has not been proven to extend OS in this trial, but the DFS effect remained strong. Unplanned subset analyses suggest a significant OS effect of oxaliplatin in patients younger than age 70.

References

	Year	Citations

Page 1